Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
CNY 8.13
(0.62%)
CNY 8.13
(0.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 298.3 Million | 358.38 Million | 305.57 Million | 328.21 Million | 285.38 Million | 83.43 Million |
| Net Income | 247.69 Million | 212.29 Million | 139.95 Million | 27.92 Million | -524.34 Million | 260.06 Million |
| Depreciation & Amortization | 76.23 Million | 109.92 Million | 102.49 Million | 83.99 Million | 81.37 Million | 78.41 Million |
| Deferred income taxes | 87.05 Thousand | 1.04 Million | 4.26 Million | 2.54 Million | 3.21 Million | -8.21 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -81.04 Million | -4.94 Million | 38.92 Million | 19.41 Million | 44.87 Million | -287.16 Million |
| Other non-cash items | 283.78 Million | 41.1 Million | 24.18 Million | 196.88 Million | 683.48 Million | 32.1 Million |
| Investing Cash Flow | -219.35 Million | 108.58 Million | -68.97 Million | -123.4 Million | -245.34 Million | -158.1 Million |
| Investments in PPE | -28.37 Million | -61.58 Million | -80.54 Million | -118.46 Million | -255.34 Million | -160.24 Million |
| Acquisitions | 264.03 Thousand | 71.41 Million | 413.93 Thousand | 23.21 Million | 5.67 Million | -5.31 Million |
| Investment purchases | -627 Million | -531 Million | -400 Million | -102 Million | -4.95 Million | - |
| Sales/Maturities of investments | 435.9 Million | 629.89 Million | 407.71 Million | 51.73 Million | 14.98 Million | 2.62 Million |
| Other Investing Activities | -144.83 Thousand | -135.19 Thousand | 3.44 Million | 22.1 Million | -5.7 Million | 4.83 Million |
| Financing Cash Flow | -94.16 Million | -182.04 Million | -176.21 Million | 79.77 Million | 50.2 Million | -99.81 Million |
| Debt repayment | -100 Thousand | -163.9 Million | -157.26 Million | -351.5 Million | -334.92 Million | -86.5 Million |
| Dividends payments | -65.13 Million | -48.85 Million | -33.38 Million | -19.95 Million | -40.7 Million | -57.37 Million |
| Common Stock Repurchased | - | - | - | - | - | -132.2 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -27.68 Million | 35.85 Million | 25.55 Million | 451.22 Million | 446.13 Million | 44.06 Million |
| Accounts receivables | -40.56 Million | 125.17 Million | 9.27 Million | 2.32 Million | 28.86 Million | -194.79 Million |
| Accounts payables | -46.6 Million | -103.34 Million | 56.47 Million | -31.78 Million | 18.96 Million | -61.21 Million |
| Inventory | 11.17 Million | -27.82 Million | -31.09 Million | 46.32 Million | -6.17 Million | -22.93 Million |
| Other working capital | -5.04 Million | 1.04 Million | 4.26 Million | 2.54 Million | 3.21 Million | -264.22 Million |
| Cash at beginning of period | 933.26 Million | 638.39 Million | 579.12 Million | 300.13 Million | 209.69 Million | 382.85 Million |
| Cash at end of period | 921.75 Million | 927.41 Million | 638.39 Million | 579.12 Million | 300.13 Million | 209.69 Million |
| Capital Expenditure | -28.37 Million | -61.58 Million | -80.54 Million | -118.46 Million | -255.34 Million | -160.24 Million |
| Effect of forex changes on cash | 1.99 Million | 4.09 Million | -1.11 Million | -5.59 Million | 199.95 Thousand | 1.31 Million |
| Net cash flow / Change in cash | -11.5 Million | 289.02 Million | 59.26 Million | 278.98 Million | 90.44 Million | -173.16 Million |
| Free Cash Flow | 269.92 Million | 296.8 Million | 225.02 Million | 209.75 Million | 30.03 Million | -76.81 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28.79 Million | 64.35 Million | 71.08 Million | 247.69 Million | 52.34 Million | 40.74 Million |
| Depreciation & Amortization | - | 19.53 Million | 19.53 Million | 76.23 Million | 18.78 Million | -42.94 Million |
| Deferred income taxes | - | - | - | 87.05 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -37.19 Million | - | -81.04 Million | -34.43 Million | 58.96 Million |
| Other non-cash items | 58.93 Million | 27.99 Million | -40.11 Million | 283.78 Million | 62.73 Million | 39.41 Million |
| Investing Cash Flow | 232.72 Million | 126.08 Million | -62.69 Million | -219.35 Million | -18.38 Million | -11.46 Million |
| Investments in PPE | -3.79 Million | -8.69 Million | -14.17 Million | -28.37 Million | -6.55 Million | -8.06 Million |
| Acquisitions | - | - | - | 264.03 Thousand | 178.25 Thousand | 30.49 Thousand |
| Investment purchases | -140 Million | -180 Million | -60 Million | -627 Million | -292 Million | -110 Million |
| Sales/Maturities of investments | 332.85 Million | 315 Million | 10 Million | 435.9 Million | 280 Million | 106.63 Million |
| Other Investing Activities | 43.66 Million | -215.11 Thousand | 1.47 Million | -144.83 Thousand | -12.26 Thousand | -63.69 Thousand |
| Financing Cash Flow | -13.19 Million | -89.14 Million | -352.36 Thousand | -94.16 Million | -1.5 Million | 10.81 Million |
| Debt repayment | -11 Million | -5 Million | - | -100 Thousand | -100 Thousand | -11 Million |
| Dividends payments | -74.9 Million | -74.9 Million | -207.84 Thousand | -65.13 Million | -26.67 Million | -186.21 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -59.47 Thousand | -94.14 Million | -352.36 Thousand | -27.68 Million | 64.97 Million | 21.99 Million |
| Accounts receivables | - | -33.82 Million | - | -40.56 Million | -40.56 Million | 54.04 Million |
| Accounts payables | - | - | - | -46.6 Million | - | - |
| Inventory | - | -3.37 Million | - | 11.17 Million | 11.17 Million | 4.91 Million |
| Other working capital | - | - | - | -5.04 Million | -5.04 Million | - |
| Cash at beginning of period | 993.24 Million | 888.3 Million | 921.75 Million | 933.26 Million | 842.82 Million | 739.98 Million |
| Cash at end of period | 1.29 Billion | 995.04 Million | 888.3 Million | 921.75 Million | 921.75 Million | 835.56 Million |
| Capital Expenditure | -3.79 Million | -8.69 Million | -14.17 Million | -28.37 Million | -6.55 Million | -8.06 Million |
| Effect of forex changes on cash | -1.87 Million | 487.28 Thousand | 875.91 Thousand | 1.99 Million | -921.47 Thousand | 50.63 Thousand |
| Net cash flow / Change in cash | 303.67 Million | 106.73 Million | -33.44 Million | -11.5 Million | 78.93 Million | 95.57 Million |
| Free Cash Flow | 83.93 Million | 64.12 Million | 16.79 Million | 269.92 Million | 92.88 Million | 88.11 Million |
ABNX
FHB
MLONL
CEFC
WSSTF
NCTKY